CD5 B Cells in autoimmune and non immune-mediated thyroid dysfunctions.

References

• Reinherz E L, Kung P C, Goldstein G, Schlossman S F. A monoclonal antibody with selective reactivity with functionally mature human thymocytes and all peripheral human T cells. J Immunol 1979; 123: 1312–1317
   PubMed Web of Science ®Google Scholar
• Royston I, Majda J, Baird S, Meserve B, Griffiths J. Human T cell antigens defined by monoclonal antibodies: the 65,000 dalton antigen of T cells (T65) is also found on chronic lymphocytic leukemic cells bearing surface immunoglobulin. J Immunol 1980; 125: 725–731
   PubMed Web of Science ®Google Scholar
• Engleman E G, Warnke R, Fox R I, Levy R. Studies of a human T lymphocyte antigen recognized by a monoclonal antibody. Proc Natl Acad Sci U.S.A 1981; 78: 1791–1795
   PubMed Web of Science ®Google Scholar
• Callgaris-Capplo F, Janossy G. Surface markers in chronic lymphoid leukemlas of B cell types. Sem Hematol 1985; 22: 1–12
   PubMedGoogle Scholar
• Bofill M, Janossy G, Janossa M, Burford G D, Seymour G J, Wernet P, Kelemen E. Human B cell development. II. Subpopulations in the human foetus. J Immunol 1985; 134: 1531–1538
   PubMed Web of Science ®Google Scholar
• Ledbetter J A, Clark E A. Surface phenotype and function of tonsillar germinal center and mantle zone B cell subsets. Human Immunol 1986; 15: 30–43
   PubMedGoogle Scholar
• Hayakawa K, Hardy R R, Parks D R, Herzenberg L A. The “Ly-1 B” cell subpopulation in normal, immunodefective, and autoimmune mice. J Exp Med 1983; 157: 202–218
   PubMed Web of Science ®Google Scholar
• Talal N. Overview of Sjögren's syndrome. J Dent Res 1987; 66: 672–674
   PubMed Web of Science ®Google Scholar
• Dauphinee M, Tovar Z, Talal N. B cells expressing CD5 are increased in Sjögren's syndrome. Arthritis Rheum 1988; 31: 642–647
   PubMed Web of Science ®Google Scholar
• Plater-Zyberk C, Malni R N, Lam K, Kennedy T D, Janossy G. A rheumatoid arthritis B cell subset expresses a phenotype similar to that in chronic leukaemia. Arthritis Rheum 1985; 28: 971–976
   PubMed Web of Science ®Google Scholar
• Younou P, Mackenzie L, Jouquan J, LeGoff P, Lydyard P. CD5 positive B cells in patients with RA: PMA mediated enhancement of detection. Ann Rheum Dis 1988; 46: 17–22
   Google Scholar
• Smerdon R A, Peakman M, Hussain M J, Wong F S, Watkins P J, Leslie R D, Vergani D. CD5+ B-cells at the onset of type I diabetes and in the prediabetic period. Diabetes Care 1994; 17: 657–664
   PubMed Web of Science ®Google Scholar
• Araga S, Kishimoto M, Adachi A, Nakayasu H, Takenaka T, Takahashi K. The C. D.5+ B cells and myasthenia gravis. Autoimmunity 1995; 20: 129–134
   PubMed Web of Science ®Google Scholar
• Maini R, Plater-Zyberk C. The significance of CD5+B cells in rheumatic diseases. Scand J Rheumatol 1988; 76: 237–242
   Google Scholar
• Erhardt C C, Mumford P A, Venables P J, Maini R N. Factors predicting a poor life prognosis in rheumatoid arthritis. Clin Exp Immunol 1988; 73: 417–423
   PubMedGoogle Scholar
• Lydyard P M, Youinou R, Cooke A. CD5 positive B cells In rheumatoid arthritis and CLL. Immunol Today 1987; 8: 37–38
   PubMedGoogle Scholar
• Boumsell K, Bernard A, Lepage V, Degos L, Lemerle J, Dausset J. Some chronic lymphocytic leukemia cell bearing surface immunoglobulin share determinants with T cells. Eur J Immunol 1978; 8: 900–904
   PubMed Web of Science ®Google Scholar
• Sidman C L, Shultz L D, Hardy R R, Hayakawa K, Herzenberg L A. Production of immunoglobulin isotypes by Ly-1 + B cells in v'able motheaten and normal mice. Science 1986; 236: 81–83
   Google Scholar
• Kearney J, Vakil M. Functional idiotype networks during B cell ontogeny. Ann Inst Pasteur Immunol 1986; 137C: 77–82
   PubMedGoogle Scholar
• Afeltra A, Paggi A, Ferri G M, DiPrima M A, Amoroso A, Startari S, Faralli A R, Bonomo L. Peripheral blood CD5+B lymphocytes and CD4+CD45RA+ T cells in Graves' disease. Endocrine Res 1993; 19: 73–85
   PubMed Web of Science ®Google Scholar
• Casali P. B1 (CD5+B) cells, autoantibodies and autoimmunity. Autoimmunity, A Continho, M D. Kazatchkine. Jon Wiley and Sons, Inc, New York 1993
   Google Scholar
• Casali P, Notkins A L. CD5+B lymphocytes polyreactive antibodies and the human B-cell repertoire. Immunol Today 1989; 10: 364–368
   PubMedGoogle Scholar
• Raveche E S. Possible immunoregulatory role for CD5+B cells. Clin Immunol Immunopathol 1990; 56: 135–150
   PubMedGoogle Scholar
• Burastero S E, Casali P, Wilder R L, Notkins A L. Monoreactive high affinity and polyreactive low affinity rheumatoid factors are produced by CD5+B cells from patients with rheumatoid arthritis. J Exp Med 1988; 168: 1979–1992
   PubMed Web of Science ®Google Scholar
• Iwatani Y, Amino N, Hidaka Y, Kaneda T, Ichihara K, Tamaki H, Matsuzuka F, Fukata S, Kuma K, Miyal K. Decreases in ab T cell receptor negative T cells and CD8 cells and an increase in CD4+CD8+ cells in active Hashimoto's disease and subacute thyroiditis. Clin Exp Immunol 1992; 87: 444–449
   PubMed Web of Science ®Google Scholar
• Watanabe K, Ywatani Y, Hidaka Y, Watanabe M, Amino N. Long-term effects of thyroid hormone on lymphocyte subsets in spleens and thymuses of mice. Endocr J 1995; 42: 661–668
   PubMed Web of Science ®Google Scholar
• Baethge B A, Levine S N, Wolf R A. Antibodies to nuclear antigens in Graves' disease. J Clin Endocrinol Metab 1988; 66: 485–488
   PubMed Web of Science ®Google Scholar
• Katakura M, Yamada T, Aizawa T, Hiramashu K, Yukimura Y, Ishihara M, Takasu N, Maruyama K, Kameko M, Kanal M, Kobayashi I. Presence of antideoxyribonucleic acid antibody in patients with hyperthyroidism of Graves' disease. J Clin Endocrinol Metab 1987; 64: 405–408
   PubMed Web of Science ®Google Scholar
• Paggi A, Caccavo D, Ferri G M, DiPrima M A, Amoroso A, Vaccaro F, Bonomo L, Afeltra A. Anti-cardiolipin antibodies in autoimmune thyroid diseases. Clin Endocrinol 1994; 40: 329–333
   PubMed Web of Science ®Google Scholar
• Iwatani Y, Amino N, Kaneda T, Ichihara K, Tamaki H, Tachi J, Matsuzuka F, Fukata S, Kuma K, Miyal K. Marked increase of CD5+B cells in hyperthyroid Graves' disease. Clin Exp Immunol 1989; 78: 196–200
   PubMed Web of Science ®Google Scholar